March 29, 2019
Researchers from the University of British Columbia and Vancouver Coastal Health Research Institute have found that a widely prescribed drug for multiple sclerosis (MS) is associated with longer survival for patients.
Source: UBC Medicine
Read More: http://ow.ly/MbK130o8WLT